ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
PharmaTher Holdings Ltd

PharmaTher Holdings Ltd (PHRM)

0.24
0.01
(4.35%)
Closed 27 November 8:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.24
Bid
0.22
Offer
0.24
Volume
65,930
0.235 Day's Range 0.245
0.14 52 Week Range 0.43
Previous Close
0.23
Open
0.24
Last Trade
500
@
0.24
Last Trade Time
Average Volume (3m)
115,541
Financial Volume
-
VWAP
-

PHRM Latest News

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

 PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch Delivering psilocybin via microneedle patch unlocks potential for desired dosage forms and pharmacokinetic profiles...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

 PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch  Focusing on partnership model for MicroDose-MN™ and...

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

 PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Leading U.S.-based CDMO to manufacture PharmaTher's proprietary ketamine products for FDA Phase 3...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome Achieving its second FDA orphan drug designation with ketamine.Building a proprietary...

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund

 PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund TORONTO, September 21, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings Ltd. (the...

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

  PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022   10 clinical sites selected to participate in the FDA Phase 2 clinical...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis Focusing on becoming a global leader in prescription-based ketamine productsAdvancing to a Phase...

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

 PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Strengthens position to become a leader in the intradermal delivery of FDA...

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

  PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression   Potential for FDA 505(b)(2) regulatory pathway approval and...

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease

  PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease   TORONTO, May 25, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.02511.62790697670.2150.2450.21836340.22756228CS
40.0314.28571428570.210.250.21122810.225943CS
120.04523.07692307690.1950.330.1851155410.24485348CS
260.029.090909090910.220.330.18748720.23698114CS
520.08500.160.430.14875670.2485735CS
156-0.17-41.46341463410.410.430.0551048650.1940899CS
260-0.015-5.882352941180.2551.240.052039520.34940104CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GTTXGeneTether Therapeutics Inc
$ 0.11
(175.00%)
2k
EPIC1CM Inc
$ 0.60
(140.00%)
1.12k
CHGXChitogenX Inc
$ 0.01
(100.00%)
5k
CACR.AKWG Resources Inc
$ 2.31
(71.11%)
100
CLDVCloud3 Ventures Inc
$ 0.025
(66.67%)
4.89M
MLKMMayo Lake Minerals Inc
$ 0.025
(-50.00%)
373k
WRUNWaverunner Capital Inc
$ 0.005
(-50.00%)
105.49k
SLZSlave Lake Zinc Corp
$ 0.01
(-50.00%)
9k
MILIMilitary Metals Corp
$ 0.345
(-47.73%)
2.28M
VIBEVibe Growth Corporation
$ 0.11
(-47.62%)
1.5k
RGXRegenx Tech Corp
$ 0.01
(-33.33%)
5.25M
CLDVCloud3 Ventures Inc
$ 0.025
(66.67%)
4.89M
PRMEPrime Drink Group Corp
$ 0.315
(5.00%)
3M
MILIMilitary Metals Corp
$ 0.345
(-47.73%)
2.28M
BTCBluesky Digital Assets Corp
$ 0.74
(-6.33%)
2.12M

Discussion

View Full Feed
Bull_Dolphin Bull_Dolphin 1 minute ago
Enjoy your final waltz of the season with Mowtilda.
We are indeed in the midst of a beautiful stretch of weather.
I will take your advice and enjoy my oak tree and local critters.
Recently the Anhinga (We call it Auntie Hinga has been hanging around, also a pair of pileated Wood
Freddie bagholder Freddie bagholder 2 minutes ago
Scott first interview today or next week?
FNMA
ksquared ksquared 4 minutes ago
The two videos in the links should lighten your mood.
I can't get enough of them...
WKRP Turkey Drop
The beginning
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175440386
The end
https://investorshub.advfn.com/boards/read_m
jeunke22 jeunke22 4 minutes ago
No I haven’t. Sorry, Proto.
LWLG
stervc stervc 5 minutes ago
StocksGoneWild, with this superb MONI "dot to dot" DD...

StocksGoneWild, very well done in connecting the dots here with MONI once again. MONI is going to be teaching some people some very important lessons about patience being a virtue. All should read what you posted below as I beli
MONI
tw0122 tw0122 8 minutes ago
2.49 +'83%
CYCN
ksquared ksquared 8 minutes ago
I've long admired your wisdom, Bull.
The weather in your neck of the woods looks perfect for making music with your bride under the old oak tree.
P.S. Thanks for the warning. I haven't checked the papers yet.
P.P.S. Good day for the last mow job of the sea
Its_TradingG Its_TradingG 9 minutes ago
UncleBillyMoney AKA LongBullyStick is definitely a paid pumper, not delusional just manipulating investors who do not know better
IGPK
sab63090 sab63090 9 minutes ago
Investor
I thought it might speed up the process to approval, but I'm not sure of when Avanex has to apply!

Your reply was funny, but I did recommend his post...

Hope you enjoy Thanksgiving.....or at least have a great market holiday on Thursday and half day on
AVXL
NinjaForest32 NinjaForest32 9 minutes ago
Thank you DewDiligence !
ENTA
Jasbg Jasbg 10 minutes ago
You wonder what is the long term plan with Novo's latest takeover (BO) ?

https://www.seafoodsource.com/news/business-finance/novo-holdings-acquiring-salmon-genetics-firm-benchmark-genetics-in-deal-worth-up-to-usd-352-million
AMRN
cardmaster114 cardmaster114 11 minutes ago
Happy Thanksgiving to everyone and enjoy your time with your family. !!!!!!!!!!!!!!!!!!!!!!!!!!
DBMM
Saving Grace Saving Grace 12 minutes ago
"ASSESS" New High Grade Underground Scenario. Maintain Strong Balance Sheet!

An Assessor accounts for past performance. Note; "Deliverables"

By the time the UK is figuring out what's really going on, restoring connections. We'll be on to new, robust leach pad recovery
HYMC
floblu14 floblu14 13 minutes ago
Enanta Pharmaceuticals: Promising RSV Developments and Strong Immunology Pipeline Justify Buy Rating

Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Enanta Pharmaceuticals (ENTA – Research Report). The associated price target was lowered to $21.00.
ENTA
Bull_Dolphin Bull_Dolphin 13 minutes ago
Good morning kk. I need to follow your advice and get from the news. Too many items making my blood boil!
Konaploinks Konaploinks 15 minutes ago
Woops
IONQ
tw0122 tw0122 16 minutes ago
CYCN $2.26 + 70%
CYCN
ddls ddls 16 minutes ago
Let's see how low ActiPatch is on Amazon.😎

Currently ActiPitch 720 hour is #341 - KT-Recovery+Wave is #120

These numbers correlate to the best seller ranking. As we can see these products have no chance of making the inve
BIEL
ksquared ksquared 16 minutes ago
Morning, PC-Tamer Larry.
Glad you're up and running on all puter cylinders.
Have a good one.
BurgerKing82 BurgerKing82 17 minutes ago
Any potential here
NAFS
ksquared ksquared 20 minutes ago
Jeremy Slinker... The last name says it all.
Morning, Bull.
These gumpermint workers are going to get theirs.
Sheriffs Musk and Ramaswamy are riding into town.
Have a good one.
Jack Torrance Jack Torrance 21 minutes ago
The moat widens. I love that IonQ has the time and resources to move onto these types of innovations, because they are so far ahead in other ways. The other quantum companies are still working on their core designs while IonQ fleshes out all their quantum/hybrid accoutrement. This feels like an auto
IONQ
tw0122 tw0122 21 minutes ago
$1.10 +78%
HWH
Konaploinks Konaploinks 21 minutes ago
It’s beginning to look a lot like Christmas. Everywhere I onQ goes.
Keep your eye on IonQ
Mele Kalikimaka!
Haouli Makahiki Hou !
IONQ
prototype_101 prototype_101 23 minutes ago
Jeunke, just looking at the report on Fintel, I see on 11/14 that Goldman Sachs and Morgan Stanley both increased their holdings by more than 100%, do you have a listing of all the increased positions since the 9/30 report?

https://fintel.io/sob/us/lwlg

There are still
LWLG